These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 34235415)

  • 1. Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial.
    Feldman PR; Fiebig KM; Piwko C; Mints BM; Brown D; Cahan DJ; Guevara-Aguirre J
    EClinicalMedicine; 2021 Jul; 37():100978. PubMed ID: 34235415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial.
    Feldman PR; Fiebig KM; Piwko C; Mints BM; Brown D; Cahan DJ; Guevara-Aguirre J
    EClinicalMedicine; 2021 Oct; 40():101124. PubMed ID: 34541479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in clinical trials of ALRV5XR treatment of androgenetic alopecia and telogen effluvium.
    Feldman PR; Feldman OJ; Guevara-Aguirre J; Fiebig KM
    Front Med (Lausanne); 2022; 9():918058. PubMed ID: 36045927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysis.
    Feldman PR; Gentile P; Piwko C; Motswaledi HM; Gorun S; Pesachov J; Markel M; Silver MI; Brenkel M; Feldman OJ; Kamen CL; Uleryk E; Guevara-Aguirre J; Fiebig KM
    Front Med (Lausanne); 2022; 9():998623. PubMed ID: 36755885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of an oral supplement containing amino acids, iron, selenium, and marine hydrolyzed collagen in subjects with hair loss (androgenetic alopecia, AGA or FAGA or telogen effluvium). A prospective, randomized, 3-month, controlled, assessor-blinded study.
    Milani M; Colombo F;
    Skin Res Technol; 2023 Jun; 29(6):e13381. PubMed ID: 37357646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical study on the efficacy and tolerability of a topical regenerative treatment in patients with telogen effluvium and mild androgenetic alopecia.
    Cedirian S; Bruni F; Quadrelli F; Caro G; Fortuna M; Rossi A; Piraccini BM; Starace M
    J Cosmet Dermatol; 2023 Dec; 22(12):3347-3351. PubMed ID: 37415302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red LED light therapy for telogen effluvium in the course of long COVID in patients with and without androgenetic alopecia.
    Gerkowicz A; Bartosińska J; Krakowski P; Karpiński R; Krasowska D; Raczkiewicz D; Kwasny M; Krasowska D
    Ann Agric Environ Med; 2024 Jun; 31(2):239-247. PubMed ID: 38940108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new combination of molecules for the treatment of androgenetic alopecia and telogen effluvium: a double-blind randomized, monocentric, placebo-controlled study.
    Rossi A; Magri F; DI Fraia M; Caro G; Fortuna MC; Piacentini M; Celleno L
    Ital J Dermatol Venerol; 2022 Feb; 157(1):78-83. PubMed ID: 33878855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postpartum Telogen Effluvium Unmasking Additional Latent Hair Loss Disorders.
    Galal SA; El-Sayed SK; Henidy MMH
    J Clin Aesthet Dermatol; 2024 May; 17(5):15-22. PubMed ID: 38779373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regenerative medicine strategies for hair growth and regeneration: A narrative review of literature.
    Shimizu Y; Ntege EH; Sunami H; Inoue Y
    Regen Ther; 2022 Dec; 21():527-539. PubMed ID: 36382136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hair Regrowth with Novel Hemp Extract: A Case Series.
    Smith GL
    Int J Trichology; 2023; 15(1):18-24. PubMed ID: 37305187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral supplementation in female telogen effluvium: a clinical and instrumental objective evidence of efficacy and tolerability of new oral cosmetic treatment.
    Starace M; Carpanese MA; Alessandrini A; Bruni F; Piraccini BM
    Ital J Dermatol Venerol; 2023 Feb; 158(1):55-59. PubMed ID: 36645365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing low-dose oral minoxidil efficacy in androgenetic alopecia: a comparative study of AGA and AGA unmasked by telogen effluvium.
    Desai DD; Nohria A; Sikora M; Anyanwu N; Shapiro J; Lo Sicco KI
    Arch Dermatol Res; 2024 Aug; 316(8):514. PubMed ID: 39133308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of adipose-derived stem cell conditioned media and minoxidil for hair regrowth in male androgenetic alopecia: a randomized, double-blind clinical trial.
    Legiawati L; Suseno LS; Sitohang IBS; Yusharyahya SN; Pawitan JA; Liem IK; Kurniawati T; Ardelia A; Paramastri K
    Stem Cell Res Ther; 2023 Aug; 14(1):210. PubMed ID: 37605227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-level laser therapy for the treatment of androgenetic alopecia in Thai men and women: a 24-week, randomized, double-blind, sham device-controlled trial.
    Suchonwanit P; Chalermroj N; Khunkhet S
    Lasers Med Sci; 2019 Aug; 34(6):1107-1114. PubMed ID: 30569416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
    Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
    J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral minoxidil use in androgenetic alopecia and telogen effluvium.
    Feaster B; Onamusi T; Cooley JE; McMichael AJ
    Arch Dermatol Res; 2023 Mar; 315(2):201-205. PubMed ID: 35244759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral and Topical Administration of a Standardized Saw Palmetto Oil Reduces Hair Fall and Improves the Hair Growth in Androgenetic Alopecia Subjects - A 16-Week Randomized, Placebo-Controlled Study.
    Sudeep HV; Rashmi S; Jestin TV; Richards A; Gouthamchandra K; Shyamprasad K
    Clin Cosmet Investig Dermatol; 2023; 16():3251-3266. PubMed ID: 38021422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogen Hairs in Women with and without Hair Loss.
    Guarrera M; Rebora A
    Skin Appendage Disord; 2017 Oct; 3(4):193-196. PubMed ID: 29177147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
    Blume-Peytavi U; Issiakhem Z; Gautier S; Kottner J; Wigger-Alberti W; Fischer T; Hoffmann R; Tonner F; Bouroubi A; Voisard JJ
    J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.